NEW YORK (GenomeWeb News) – 23andMe today announced it has acquired CureTogether for an undisclosed amount.

Based in Mountain View, Calif., CureTogether is a community-based health site where members can share quantitative information about more than 500 medical conditions. The purchase is the first by 23andMe, which said that it provides the firm with "technology and talent that will improve 23andMe's ability to gather data for research, while also providing customers with engaging and meaningful interactions in 23andMe's online community."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: caution urged in use of gene drives, and more.

NIH's Sally Rockey examines the tapped and untapped potential of the NIH peer reviewer pool.

PLOS Biology has asked researchers how they envision the future of genetics and genomics.

Representative Lamar Smith brings back a provision to require the National Science Foundation to certify that each study it funds is "in the national interest."